Hermes L. Ames

The Arena Group Deepens Investment in Advertising Data Infrastructure, Hires New VP to Lead Strategy

Retrieved on: 
Wednesday, October 26, 2022

As the first step in this process, the company hired Stephanie Mazzamaro, who will serve as VP, Data Strategy and Operations, Advertising, Partnerships, and Revenue.

Key Points: 
  • As the first step in this process, the company hired Stephanie Mazzamaro, who will serve as VP, Data Strategy and Operations, Advertising, Partnerships, and Revenue.
  • View the full release here: https://www.businesswire.com/news/home/20221026005020/en/
    Stephanie Mazzamaro will serve as VP, Data Strategy and Operations, Advertising, Partnerships & Revenue (Photo: Business Wire)
    Mazzamaro joins The Arena Group after four years at Trusted Media Brands where she served as VP, Data Product & Operations.
  • Im excited to have this incredible opportunity to lead The Arena Groups major data initiatives, said Stephanie.
  • The Arena Group recently reported a strong second-quarter earnings report, including a record 87% revenue growth, driven largely by advertising and third-party revenue generation.

Cambrian BioPharma Announces its Scientific Advisory Board led by Two Veteran R&D Executives

Retrieved on: 
Wednesday, September 14, 2022

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.

Key Points: 
  • NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.
  • SAB reports are shared with individual pipeline companies for consideration in project strategy and planning and are also shared with the Cambrian BioPharma Board of Directors.
  • Moving forward Cambrian may add further SAB members or ad-hoc advisors as its pipeline grows and matures.
  • "Cambrian BioPharma is honored to have two highly experienced R&D executives to assist with our pursuit of expanding healthspan in the 21st century," said Brenton L. Saunders, Cambrian BioPharma Board of Directors.

UBCO attracts international talent with five new board and executive appointments

Retrieved on: 
Wednesday, February 16, 2022

These international appointments accompany UBCO's expeditious growth into global markets driven by record demand, deepening distribution US networks, and new global operations centres.

Key Points: 
  • These international appointments accompany UBCO's expeditious growth into global markets driven by record demand, deepening distribution US networks, and new global operations centres.
  • On these appointments, UBCO CEO Katherine Sandford says: "We are delighted to welcome these incredibly talented and diverse minds to the board and executive team.
  • Keeping pace with their continued business growth, UBCO has also appointed two new executive team members to kickoff 2022.
  • Founded in Tauranga, New Zealand, UBCO can now be found in international markets including the United States, Australia, and Europe.